Concepedia

Bertold J. Vilner

BJ

Statistics

Publications

16

Citations

1.5K

H-Index

15

Active since

1993

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

George Washington University

Washington University Medical Center

National Institute on Drug Abuse

Bertold J. Vilner is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, pharmacology, and ligand binding.

Publications per year

1993–2000

16

Publications

16

Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

Bertold J. Vilner, Christy S. John, W D Bowen · PubMed · 1995 · 488 citations

, , +10

Modulation of Cellular Calcium by Sigma-2 Receptors: Release from Intracellular Stores in Human SK-N-SH Neuroblastoma Cells

Bertold J. Vilner, Wayne D. Bowen · Journal of Pharmacology and Experimental Therapeutics · 2000 · 198 citations

, , +17

Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.

Christy S. John, Bertold J. Vilner, Brian C. Geyer et al. · PubMed · 1999 · 98 citations

, , +12

A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.

Christy S. John, W. Don Bowen, T. Saga et al. · PubMed · 1993 · 97 citations

, , +17

Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinity

Wayne D. Bowen, Bertold J. Vilner, Wanda Williams et al. · European Journal of Pharmacology · 1995 · 94 citations

, , +12

1–5 of 16